Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Coherus BioSciences
AddedFeb 19, 2024
UpdatedJun 18, 2026
Coherus BioSciences

Coherus BioSciences

Public

Coherus BioSciences, a leading biologics firm, focuses on delivering quality biosimilar therapeutics globally.

HQ
Redwood City, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded in Redwood City, Coherus BioSciences is a pioneering biologics company dedicated to expanding patient access to high-quality biosimilar therapeutics in regulated markets worldwide. The company's core mission is to deliver medicines that make a significant impact on people with life-altering diseases. Coherus offers a diversified portfolio of next-generation immuno-oncology therapies aimed at transforming cancer treatment and extending survival for patients with difficult-to-treat tumors.

Notable figures affiliated with Coherus BioSciences include industry-leading scientists and healthcare professionals. The company has garnered significant investment from prominent venture capital firms and strategic partners. Key achievements include the FDA approval of LOQTORZI™ (toripalimab-tpzi), an innovative therapy for recurrent cancer, marking a significant milestone in their mission to provide accessible and effective treatments. Coherus BioSciences continues to make a substantial impact in the biopharmaceutical industry, driving innovation and improving patient outcomes globally.

Coherus BioSciences - Similar Companies

Z Squared logo

Z Squared

coeptistx.com

Clovis Oncology logo

Clovis Oncology

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

CytomX Therapeutics logo

CytomX Therapeutics

cytomx.com

Coare Biotechnology logo

Coare Biotechnology

Omeros logo

Omeros

omeros.com

BeOne Medicines logo

BeOne Medicines

beigene.com

MacroGenics logo

MacroGenics

macrogenics.com

Harmony Biosciences logo

Harmony Biosciences

Brii Biosciences logo

Brii Biosciences

briibio.com

Kronos Bio logo

Kronos Bio

NextCure logo

NextCure

nextcure.com

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Coherus BioSciences - Quick Facts

Who are Coherus BioSciences' competitors?

Companies similar to Coherus BioSciences include Z Squared, Clovis Oncology, Cogent Biosciences and CytomX Therapeutics.

When was Coherus BioSciences founded?

Coherus BioSciences was founded in 2010.

Where is Coherus BioSciences' headquarters located?

Coherus BioSciences' headquarters is located in Redwood City, CA, US.

When was Coherus BioSciences' last funding round?

Coherus BioSciences' most recent funding round was for $50M (USD) in May 2023.

How much has Coherus BioSciences raised to-date?

As of May 16, 2023, Coherus BioSciences has raised a total of $1.3B (USD).

How many employees does Coherus BioSciences have?

Coherus BioSciences has 359 employees as of Feb 6, 2024.

Coherus BioSciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biosimilar Therapeutics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research